Dtsch Med Wochenschr 2009; 134(45): 2302-2304
DOI: 10.1055/s-0029-1241945
Kommentar | Commentary
Pharmakologie, Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York

Antihypertensiva „over the counter”?

Antihypertensives as over-the-counter drugs?T. Unger1
  • 1Center for Cardiovascular Research/Institut für Pharmakologie, Charité – Universitätsmedizin Berlin
Further Information

Publication History

eingereicht: 9.9.2009

akzeptiert: 1.10.2009

Publication Date:
29 October 2009 (online)

Literatur

  • 1 Egan B M, Nesbitt S D, Julius S. Prehypertension: should we be treating with pharmacologic therapy?.  Ther Adv Cardiovasc Dis. 2008;  2 305-314
  • 2 Julius S, Nesbitt S D, Egan B M, Weber M A, Michelson E L, Kaciroti N, Black H R, Grimm Jr R H, Messerli F H, Oparil S, Schork M A. Trial of Preventing Hypertension (TROPHY) Study Investigators . Feasibility of treating prehypertension with an angiotensin-receptor blocker.  N Engl J Med. 2006;  354 1685-1697
  • 3 Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder R E, Trenkwalder P, Haller H, Dominiak P. PHARAO Study Group . The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.  J Hypertens. 2008;  26 1487-1496
  • 4 Schunkert H. Pharmacotherapy for prehypertension – mission accomplished?.  New Engl J Med. 2006;  354 1742-1744
  • 5 Unschuld, PU. Produkt Mensch. Süddeutsche Zeitung Nr. 300 27./28.12.2008
  • 6 Wald N J, Law M R. A strategy to reduce cardiovascular disease by more than 80 %.  Brit Med J. 2003;  326 1419

Prof. Dr. med. Thomas Unger

Direktor, Center for Cardiovascular Research, Institut für Pharmakologie, Charité – Universitätsmedizin Berlin

Hessische Straße 3–4

10115 Berlin

    >